Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronit Mazor

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicityRonit Mazor, Emily M King, Masanori Onda, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2022
Differential T cell immune responses to deamidated adeno-associated virus vectorSo Jin Bing, Sune Justesen, Wells W Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2012
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin ARonit Mazor, Aaron N Vassall, Jaime A Eberle, et al.
Nature Communications|March 3, 2026
Integrated computational and experimental immunoengineering of adeno-associated virus capsid T cell epitopes in miceSojin Bing, Arya Eskandarian, Sean Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopesRonit Mazor, Jaime A Eberle, Xiaobo Hu, et al.
Communications Biology|September 9, 2021
In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidanceLu Shan, Nydia Van Dyk, Nantaporn Haskins, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicityRonit Mazor, Emily M King, Masanori Onda, et al.
Molecular Therapy. Methods & Clinical Development|February 25, 2022
Differential T cell immune responses to deamidated adeno-associated virus vectorSo Jin Bing, Sune Justesen, Wells W Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2012
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on Pseudomonas exotoxin ARonit Mazor, Aaron N Vassall, Jaime A Eberle, et al.
Nature Communications|March 3, 2026
Integrated computational and experimental immunoengineering of adeno-associated virus capsid T cell epitopes in miceSojin Bing, Arya Eskandarian, Sean Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2014
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopesRonit Mazor, Jaime A Eberle, Xiaobo Hu, et al.
Communications Biology|September 9, 2021
In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidanceLu Shan, Nydia Van Dyk, Nantaporn Haskins, et al.
Pageof 3